HT
ELV icon

Headlands Technologies’s Elevance Health ELV Stock Holding History

Headlands Technologies’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14
Closed -$5.45K – 809
2025
Q2 		$5.45K Sell
14
-2,820
-100% -$1.13M ﹤0.01% 1055
2025
Q1 		$1.23M Sell
2,834
-2,975
-51% -$1.19M 0.14% 162
2024
Q4 		$2.14M Buy
5,809
+1,000
+21% +$418K 0.22% 112
2024
Q3 		$2.5M Buy
4,809
+1,065
+28% +$569K 0.29% 72
2024
Q2 		$2.03M Buy
3,744
+2,920
+354% +$1.54M 0.22% 95
2024
Q1 		$427K Buy
824
+752
+1,044% +$374K 0.1% 218
2023
Q4 		$34K Sell
72
-657
-90% -$304K 0.01% 587
2023
Q3 		$317K Buy
729
+448
+159% +$203K 0.16% 140
2023
Q2 		$125K Buy
+281
New +$130K 0.04% 356
2023
Q1 		– Sell
-1,190
Closed -$610K – 559
2022
Q4 		$610K Buy
+1,190
New +$604K 0.48% 60

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Headlands Technologies's ELV Position: Q3 2025 in Review

Headlands Technologies sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 14 shares — an estimated $5.45K sold.

Headlands Technologies first reported a position in ELV in Q4 2022 and held it in 10 quarters. The position peaked at $2.5M in Q3 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Headlands Technologies reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Headlands Technologies sold 14 Elevance Health shares in Q3 2025, an estimated $5.45K.
  • Headlands Technologies first reported a position in Elevance Health in Q4 2022 and held it in 10 quarters.
  • Headlands Technologies's Elevance Health position peaked at $2.5M in Q3 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Headlands Technologies's 13F filing for Q3 2025, filed 12 Nov 2025.